CD8A and cancer: Another study with a mouse lung adenocarcinoma model showed that deletion of Treg-specific ST2 enhanced tumor-infiltrating CD8+ T cells and reduced tumor burden, suggesting a critical function of ST2 in Treg-mediated immunosuppression in cancer [114].